Trial Profile
Safety and efficacy study of high-dose Micafungin in allogeneic stem cell transplantation (allo SCT) antifungal treatment and prophylaxis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Mycoses
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2015 New trial record